5G ham ra ZW,D weik R A.Primary pulmonary hypertension:an overview of epidem iology and pathogenesis[J].Cleve Clin J M ed,2003,70(1):2-8.
6Law MA, Grifka RG, Mullins CE, et al. Atrial septostomy improves survival in select patients with pulmonary hypertension. Am Heart J, 2007, 153(5) :779-784.
7Mahapatra S, Nishimura RA, Oh JK, et al. The prognostic value of pulmonary vascular capacitance determined by Doppler echocardiography in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr, 2006, 19 (8) : 1045- 1050.
8Grifoni S, Vanni S, Magazzini S, et al. Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events. Arch Intern Med, 2006, 166(19) :2151-2156.
9Sakamaki F, Kyotani S, Nagaya N, et al. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy. Circulation, 2000, 102 (22) :2720-2725.
10Hoeper MM, Schwarze M, Ehlerding S, et al. Long-term treatment of primary pulmonary hypertension with aerosolized ilo-prost, a prostacyclin analogue. N Engl J Med, 2000, 342(24) : 1866-1870.
